• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

The Safety of Neoadjuvant Therapy with Polyethylene Glycol Liposome Adriamycin Combined with Docetaxel in Patients with Breast Cancer Complicated by Axillary Lymph Node Metastasis
CONCLUSION: The combination of polyethylene glycol liposome adriamycin and docetaxel in neoadjuvant chemotherapy in patients with early BC with axillary lymph node metastasis has certain cardiac safety. And in the human epidermal growth factor receptor-2 (HER-2) positive population, polyethylene glycol liposome adriamycin combined with docetaxel and trastuzumab also has certain cardiac safety.PMID:36947649
Source: Alternative Therapies in Health and Medicine - March 22, 2023 Category: Complementary Medicine Authors: Li Wang Ziru Guo Shuo Zhang Xiangmei Zhang Xiaochong Zhang Dengxiang Liu Yunjiang Liu Source Type: research

< em > EGFR < /em > mutations and high PD-L1 expression of lung squamous cell carcinoma patients achieving pCR following neoadjuvant immuno-chemotherapy: Case report
Front Oncol. 2022 Oct 19;12:1008932. doi: 10.3389/fonc.2022.1008932. eCollection 2022.ABSTRACTThe treatment of lung cancer has fully entered the era of immunotherapy, which has significantly elevated the survival rate of patients with advanced non-small cell lung cancer (NSCLC), thus shedding light on resectable NSCLC. Previous clinical trial data suggested that neoadjuvant immuno-chemotherapy obtained a significant objective response rate (ORR) and disease control rate (DCR). Here, a case that achieved an excellent outcome following neoadjuvant immuno-chemotherapy was reported. The patient admitted to our hospital was 58 ...
Source: Cancer Control - November 7, 2022 Category: Cancer & Oncology Authors: Xiangyu Xu Zixia Shi Dan Fu Depei Huang Zheng Ma Source Type: research

Efficacy Of Pegylated Liposomal Doxorubicin-based Neoadjuvant Chemotherapy In Breast Cancer: A Single Center Experience
CONCLUSION: The use of PLD-containing chemotherapeutics in neoadjuvant settings might have benefits for non-metastatic operable breast cancer in Taiwanese females.PMID:33743571
Source: Clinical Genitourinary Cancer - March 21, 2021 Category: Cancer & Oncology Authors: I-Chen Tsai Chih-Chiang Hung Hung Source Type: research

Pages: 1  2  3  4  5  6